Devroe Eric
Insider CIK 1950573 · ACRV Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 604 | $2.01 | $1.2K | 146,349 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 604 | $2.01 | $1.2K | 146,349 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 72,981 | — | $0 | 146,953 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-05-14 | 2026-05-18 | 613 | $1.92 | $1.2K | 73,972 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 186,728 | — | $0 | 186,728 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-02-14 | 2026-02-18 | 723 | $1.63 | $1.2K | 74,585 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | P Buy | 2026-01-13 | 2026-01-15 | 10,000 | $1.72 | $17.2K | 75,308 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-11-14 | 2025-11-18 | 613 | $2.24 | $1.4K | 65,308 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-08-14 | 2025-08-18 | 613 | $1.39 | $852 | 65,921 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-05-14 | 2025-05-16 | 613 | $1.14 | $699 | 66,534 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-03-01 | 2025-03-04 | 140,540 | — | $0 | 140,540 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-19 | 724 | $5.42 | $3.9K | 67,147 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-11-14 | 2024-11-18 | 613 | $7.92 | $4.9K | 67,871 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-08-14 | 2024-08-16 | 613 | $7.02 | $4.3K | 68,484 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise deriv | 2024-05-17 | 2024-05-21 | 10,000 | — | $0 | 86,615 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise | 2024-05-17 | 2024-05-21 | 10,000 | $1.04 | $10.4K | 69,097 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-05-14 | 2024-05-16 | 613 | $8.36 | $5.1K | 59,097 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-11-27 | 90,090 | — | $0 | 90,090 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-02-14 | 2024-02-16 | 723 | $3.40 | $2.5K | 59,710 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2023-11-14 | 2023-11-16 | 2,450 | $5.08 | $12.4K | 60,433 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise deriv | 2023-06-05 | 2023-06-06 | 9,225 | — | $0 | 96,615 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | M Exercise | 2023-06-05 | 2023-06-06 | 9,225 | $1.04 | $9.6K | 62,883 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2022-11-14 | 2022-11-16 | 100,150 | — | $0 | 100,150 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2022-11-14 | 2022-11-16 | 33,383 | — | $0 | 53,658 | SEC↗ |